Haematology

Haematology Department – National Institute of ENT

The Haematology Department at the National Institute of ENT specializes in the diagnosis, treatment, and management of blood-related disorders, including those that may affect ear, nose, and throat (ENT) health. The department provides comprehensive care for various hematological conditions that can influence ENT procedures, such as anemia, bleeding disorders, and clotting abnormalities.


Services and Activities

Diagnosis and Treatment of Blood Disorders

  • The department provides diagnostic services and medical treatment for a range of hematological conditions, including anemia, leukemia, lymphoma, and coagulation disorders.

  • It is equipped with advanced diagnostic tools and lab tests to accurately identify blood-related diseases that may affect ENT health.

Management of Coagulation and Bleeding Disorders

  • The department specializes in the care of patients with bleeding disorders, such as hemophilia and von Willebrand disease, which are critical when preparing for ENT surgeries.

  • Specialized treatments, including blood clotting factor replacement therapy and other interventions, are provided to manage bleeding risks during surgeries.

Management of Anemia

  • For patients with iron-deficiency anemia, sickle cell anemia, or other types of anemia, the department offers treatments that help improve overall health and well-being, which is crucial for recovery after ENT surgeries and procedures.

  • Blood transfusions, iron supplements, and other therapeutic measures are employed to manage the condition.

Blood Cancer Care

  • The department provides care for patients with blood cancers such as leukemia, lymphoma, and myeloma that may present with symptoms affecting the ENT region, including swelling, bleeding gums, or infections.

  • Treatment includes chemotherapy, radiation, and other therapies tailored to the patient’s specific needs.

Preoperative Assessment and Management

  • For patients undergoing ENT surgery, the department conducts a thorough preoperative evaluation of their blood health, especially those with a history of hematological disorders.

  • This helps mitigate risks related to blood loss or clotting during surgical procedures, ensuring patient safety.

Bone Marrow Disorders

  • The department manages bone marrow disorders, including conditions like myelodysplastic syndromes or aplastic anemia, which can impact blood production and lead to complications in ENT procedures.

  • Regular monitoring and treatment help manage these conditions to prevent bleeding or infections post-surgery.

Thrombosis and Clotting Disorders

  • The department provides care for thrombophilia (tendency to form abnormal blood clots) and deep vein thrombosis (DVT), which are important for ENT patients who may be at higher risk of clot formation due to surgery or immobility.

  • Medical treatments, including anticoagulants and thrombolytics, are used to manage these conditions effectively.


Team of Experts

The Haematology Department is staffed by hematologists, oncologists, and clinical pathologists who work closely with ENT specialists. This multidisciplinary collaboration ensures comprehensive care for patients with both hematological and ENT conditions.


Goal of the Haematology Department

The Haematology Department at the National Institute of ENT aims to provide high-quality care for patients with blood disorders, ensuring their optimal health for ENT interventions. The department’s focus on comprehensive blood health management allows for safer surgical procedures and better patient outcomes.

© All rights reserved © 2025 EN
Design & Developed BY ITSOFT